Literature DB >> 25790983

FDA approves first biosimilar, zarxio.

Janet Colwell.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25790983     DOI： 10.1158/2159-8290.CD-ND2015-002

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


× No keyword cloud information.
  3 in total

Review 1.  Differentiating biosimilarity and comparability in biotherapeutics.

Authors:  Valderilio Azevedo; Brian Hassett; João Eurico Fonseca; Tatsuya Atsumi; Javier Coindreau; Ira Jacobs; Ehab Mahgoub; Julie O'Brien; Ena Singh; Steven Vicik; Brian Fitzpatrick
Journal:  Clin Rheumatol       Date:  2016-10-12       Impact factor: 2.980

2.  Community pharmacists' preparedness for substituting biologics and dispensing biosimilars - Lessons learned from a multinational survey.

Authors:  Isabelle Arnet; Melina Verbeek; Birna Almarsdóttir Anna; Liese Barbier; Rhonda Clifford; Christiane Eickhoff; Kurt Hersberger; Isabelle Huys; Kenny Lee; Kritsanee Saramunee; Martin Schulz; David Zgarrick; Kati Sarnola
Journal:  Explor Res Clin Soc Pharm       Date:  2021-10-22

3.  Considerations for the US health-system pharmacist in a world of biosimilars.

Authors:  Andrea Zlatkus; Todd Bixby; Kavitha Goyal
Journal:  Drugs Context       Date:  2020-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.